Gate Bioscience
Brisbane
About Gate Bioscience
Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases. The company pioneers a novel therapeutic modality called Molecular Gates, small-molecule drugs that selectively block and eliminate disease-causing proteins before they are secreted. Their discovery platform combines a library of privileged gate molecules, specialized assays focused on protein secretion, and deep biological insights into the secretory translocon (Sec61) pathway. By binding to the secretory channel of specific target proteins, molecular gates prevent their export and cause their intracellular degradation, which could provide oral, highly selective therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Total funding: $125.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2025)
- Website: gatebio.com
Industries & Categories
Biotechnology, Life Science, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/gate-bioscience-48075 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.